Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act
Inactive
- Assistance listing
- 93.664
- Agency
-
Centers for Medicare and Medicaid Services
Department of Health and Human Services
- Grant awards
- 15 $47,831,918 in federal obligations
Program facts
- Assistance type
-
- Cooperative Agreement
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Department of Health and Human Services Centers for Medicare and Medicaid Services funds state Medicaid agency projects to increase substance use disorder treatment provider capacity through education, training, and technical assistance under CFDA 93.664, with the most recent grant award dated September 30, 2019.
All 15 awards in the portfolio were issued in 2019 as Cooperative Agreements with a combined federal obligation of $47.8 million. This program has not issued new grant awards since 2019; the last opportunity (CMS-2C2-19-001) closed on August 9, 2019. No recent grant opportunities are currently open.
The funded projects assess and address gaps in Medicaid SUD provider capacity within state systems. Representative awards include Virginia's project analyzing current capacity, barriers, and gaps in its SUD treatment network with focus on pregnant and postpartum women and individuals with recent incarceration history ($4,952,821.50); Michigan's effort to expand treatment access and medication-assisted treatment services amid one of the nation's highest opioid overdose rates ($3,338,479.93); and Alabama's provider capacity initiative emphasizing whole-person integrated care and telehealth expansion ($5,209,270.46). Additional funded activities range from Connecticut's continued SUD provider access work ($3,066,484) to smaller planning and infrastructure efforts. Award completion dates cluster between 2021 and 2025, with several multi-year implementation periods extending into 2024 and 2025.
Program economics show individual awards ranging from approximately $198 thousand to $5.2 million. CMS alone funds the entire program; no other federal agencies participate.
This program appears dormant for new applications. Organizations should verify current funding status with CMS directly before investing in proposal development.
Objective and description
- Objective
Section 1003 Demonstration Project to Increase Substance Use Provider Capacity authorized a new demonstration to help states increase Medicaid substance use disorder provider capacity through education, training, and technical assistance. Through thi
Grant opportunities
| Opportunity | Status | Posted | Applications due |
|---|---|---|---|
| Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act: Section 1003 Demonstration Project to Increase Substance Use Provider Capacity | Closed |
Grant awards
Latest 10 of 15 listed here. See the rest on GovTribe.
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | Alabama Medicaid Agency | $5,209,271 | 11% |
| 2 | VA Department Of Medical Assistance Service | $4,952,822 | 10% |
| 3 | Illinois Department Of Healthcare & Family Services | $4,852,626 | 10% |
| 4 | Department Of Health Care Finance | $4,373,811 | 9% |
| 5 | Health Care Authority | $3,837,024 | 8% |
| 6 | Health & Human Services, Rhode Island Executive Office Of | $3,685,940 | 8% |
| 7 | Delaware Dept Of Health And Social Services | $3,678,132 | 8% |
| 8 | Michigan Department Of Health And Human Services | $3,338,480 | 7% |
| 9 | Department Of Social Services Connecticut | $3,066,484 | 6% |
| 10 | Indiana Family And Social Serv | $2,657,647 | 6% |
10 of 15 recipients listed here. See the rest on GovTribe.
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2025 | -$129,735 |
| FY2023 | -$2,212,312 |
| FY2022 | -$899,470 |
| FY2021 | $2,784,653 |
| FY2020 | -$155,377 |
| FY2019 | $48,444,159 |
Quick answers
What is Assistance Listing 93.664?
Assistance Listing 93.664 is Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, a federal grant program run by Centers for Medicare and Medicaid Services (Department of Health and Human Services). It is inactive.
What is the CFDA number for Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act?
Its CFDA number is 93.664: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.664 awarded?
15 grant awards under 93.664 have obligated $47,831,918 in federal funds to 15 recipients.
Who receives the most funding from 93.664?
The recipients obligated the most under Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act are Alabama Medicaid Agency ($5,209,271), VA Department Of Medical Assistance Service ($4,952,822) and Illinois Department Of Healthcare & Family Services ($4,852,626).
How much did 93.664 obligate in fiscal year 2025?
Grants under 93.664 obligated -$129,735 in federal funds in fiscal year 2025.
Are there open grant opportunities under 93.664?
No opportunity listed under 93.664 is open now. The latest, Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act: Section 1003 Demonstration Project to Increase Substance Use Provider Capacity, was posted on June 25, 2019.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program